Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 1Sedation 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Parasomnias 1Pain, Postoperative 1Neoplasm Metastasis 1Melanoma 1Leiomyosarcoma 1Glioma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1Advanced Malignancies 1

Interventions

Injections 2Midazolam 1Drug Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Malignancies × Midazolam × Clear all
NCT07426757 2026-06-01

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Pfizer

Phase 1 Recruiting
120 enrolled

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡